These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28185098)

  • 1. Advancement in bioprocess technology: parallels between microbial natural products and cell culture biologics.
    Bandyopadhyay AA; Khetan A; Malmberg LH; Zhou W; Hu WS
    J Ind Microbiol Biotechnol; 2017 May; 44(4-5):785-797. PubMed ID: 28185098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 'Omics technology to rationally improve industrial mammalian cell line performance.
    Lewis AM; Abu-Absi NR; Borys MC; Li ZJ
    Biotechnol Bioeng; 2016 Jan; 113(1):26-38. PubMed ID: 26059229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study.
    Bareither R; Bargh N; Oakeshott R; Watts K; Pollard D
    Biotechnol Bioeng; 2013 Dec; 110(12):3126-38. PubMed ID: 23775295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methanol-based industrial biotechnology: current status and future perspectives of methylotrophic bacteria.
    Schrader J; Schilling M; Holtmann D; Sell D; Filho MV; Marx A; Vorholt JA
    Trends Biotechnol; 2009 Feb; 27(2):107-15. PubMed ID: 19111927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly isolated microorganisms with potential application in biotechnology.
    Pessôa MG; Vespermann KAC; Paulino BN; Barcelos MCS; Pastore GM; Molina G
    Biotechnol Adv; 2019; 37(2):319-339. PubMed ID: 30664944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in technology supporting biopharmaceutical production from mammalian cells.
    Butler M; Meneses-Acosta A
    Appl Microbiol Biotechnol; 2012 Nov; 96(4):885-94. PubMed ID: 23053101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioprocess control from a multivariate process trajectory.
    Cimander C; Mandenius CF
    Bioprocess Biosyst Eng; 2004 Dec; 26(6):401-11. PubMed ID: 13680336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial Biotechnology-2020.
    Timmis K; Ramos JL; de Vos W; Vlaeminck S; Prieto A; Danchin A; Verstraete W; de Lorenzo V
    Microb Biotechnol; 2016 Sep; 9(5):529. PubMed ID: 27509838
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings of the 10th European Congress of Biotechnology (ECB10): Novel bioactive substances and bioremediation technologies. Madrid, Spain, July 2001.
    J Biotechnol; 2002 Nov; 99(3):173-330. PubMed ID: 12385706
    [No Abstract]   [Full Text] [Related]  

  • 10. Industrial microbiology.
    Vandamme EJ
    Curr Opin Microbiol; 2010 Jun; 13(3):253-4. PubMed ID: 20382556
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechnological production of value-added compounds by ustilaginomycetous yeasts.
    Paulino BN; Pessôa MG; Molina G; Kaupert Neto AA; Oliveira JVC; Mano MCR; Pastore GM
    Appl Microbiol Biotechnol; 2017 Nov; 101(21):7789-7809. PubMed ID: 28921339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process technology for production and recovery of heterologous proteins with Pichia pastoris.
    Jahic M; Veide A; Charoenrat T; Teeri T; Enfors SO
    Biotechnol Prog; 2006; 22(6):1465-73. PubMed ID: 17137292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of biologically inspired next-generation factories for chemicals.
    Schmidt-Dannert C
    Microb Biotechnol; 2017 Sep; 10(5):1164-1166. PubMed ID: 28805317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in in-situ product recovery (ISPR) in whole cell biotechnology during the last decade.
    Van Hecke W; Kaur G; De Wever H
    Biotechnol Adv; 2014 Nov; 32(7):1245-1255. PubMed ID: 25072605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production of plant-derived natural products in yeast cells - A review].
    Wang D; Dai Z; Zhang X
    Wei Sheng Wu Xue Bao; 2016 Mar; 56(3):516-29. PubMed ID: 27382793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing unexpected events in the manufacturing of biologic medicines.
    Grampp G; Ramanan S
    BioDrugs; 2013 Aug; 27(4):305-16. PubMed ID: 23529766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodologies for the characterization of microbes in industrial environments: a review.
    Maukonen J; Mättö J; Wirtanen G; Raaska L; Mattila-Sandholm T; Saarela M
    J Ind Microbiol Biotechnol; 2003 Jun; 30(6):327-56. PubMed ID: 12764674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental biotechnology in China: progress and prospect.
    Zhong W; Chen J
    Biotechnol J; 2006 Nov; 1(11):1241-52. PubMed ID: 17109489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in heterologous expression of fungal natural products-A review].
    Ma Z; Li W; Yin W
    Wei Sheng Wu Xue Bao; 2016 Mar; 56(3):429-40. PubMed ID: 27382786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in developing and applying Streptomyces chassis - A review].
    Xiao L; Deng Z; Liu T
    Wei Sheng Wu Xue Bao; 2016 Mar; 56(3):441-53. PubMed ID: 27382787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.